Pharmaceutical Industry News | The Pharmaletter
WEBSep 5, 2024 · Centivo secures $75 million to expand affordable healthcare. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of offering affordable care to employees and their families. 25 September 2024. More Pharmaceutical News >.
Pharma, Biotech and Generics Industry News | The Pharmaletter
WEBSep 24, 2024 · Italian biotech Genespire—which is developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases—has announced the closing of a 46.6 million euros ($52 million) Series B financing. 25 September 2024. Healthcare plan provider Centivo has raised $75 million in equity and debt financing to support its goal of ...
Pharma and Biotech Insights | The Pharmaletter
WEBSep 20, 2024 · Domestic drugs and foreign drugs, the production of which is localized in Russia, will be given a priority when included in the list of vital and essential drugs (VED) and expensive drugs, according to a recent resolution signed by the Russian government, The Pharma Letter’s local correspondent reports. 1 August 2024.
About The Pharma Letter | The Pharmaletter
WEBThe Pharma Letter offers high value news and insights for people with a professional interest in the global pharmaceutical, biotech, generic and biosimilar industries. Headquartered in London, the company draws from a network of foreign correspondents, with healthcare journalists around the world providing insight on local markets.
Login - The Pharmaletter
WEB4 days ago · The Pharma Letter. 39-43 Putney High Street, Putney London, SW15 1SP United Kingdom
AstraZeneca/P&G's Prilosec OTC cleared by FDA for frequent …
WEB29 June 2003. The US Food and Drug Administration has approved AstraZeneca's proton pump inhibitor antiulcerant Prilosec (omeprazole) as the first over-the-counter treatment for frequent heartburn. The OTC version will be marketed in the USA by Procter & Gamble, in a 20mg dose, and is scheduled for launch this fall.
2024 US Generic & Biosimilar Medicines Savings Report
WEBSep 6, 2024 · The Biosimilars Council, alongside the Association for Accessible Medicines (AAM), released its 2024 US Generic & Biosimilar Medicines Savings Report - highlighting the promise of these lower cost medicines for patients while also underscoring the extreme fragility of this vital industry.
Chinese approval unlocks huge new market for Wegovy
WEBJun 26, 2024 · This article is accessible to registered users, to continue reading please register for free.. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the …
AbCellera acquires TetraGenetics | The Pharmaletter
WEB14 September 2021. Canadian biotech AbCellera (Nasdaq: ABCL) yesterday announced it has acquired TetraGenetics, a USA-based company with a proprietary platform for generating recombinant human ion channels and other transmembrane proteins. The all-cash transaction includes an undisclosed upfront payment, the potential for …
Billion dollar deal for Swiss RNA start-up
WEBSep 5, 2024 · Lausanne-based Haya Therapeutics has partnered with Eli Lilly to advance RNA-based drug discovery for obesity and metabolic conditions, building on Lilly’s GLP-1 agonist tirzepatide. Haya will receive an upfront payment and up to $1 billion in milestone payments, plus royalties. Haya, founded in 2019, focuses on precision medicines targeting long non-coding RNAs, including its lead candidate ...